Cellular Uptake of Antisense Morpholino Oligomers Conjugated to Arginine-Rich Peptides

Bioconjugate Chemistry

Volumn 15, Issue 2, 2004, Pages 290-299

  Moulton, Hong M ^a   Nelson, Michelle H ^a   Hatlevig, Susie A ^a   Reddy, Muralimohan T ^a   Iversen, Patrick L ^a  

^a AVI BIOPHARMA INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CELL CULTURE; GENES; PEPTIDES; RNA;

ANTISENSE; ANTISENSE ACTIVITY; ANTISENSE AGENT; BIOSTABILITY; CELLULAR UPTAKE; CROSSLINKER; CULTURE CONDITIONS; GENE FUNCTION; LOW TOXICITY; SEQUENCE SPECIFICITY;

OLIGOMERS;

ANTENNAPEDIA PROTEIN; ANTISENSE OLIGONUCLEOTIDE; ARGININE; ARGINYLARGINYLARGINYLARGINYLARGINYLARGINYLARGINYLARGINYLARGINYLPHENYLALANYL PHENYLALANYLCYSTEINE CARBOXAMIDE; CARRIER PROTEIN; DIAMIDE; DROSOPHILA PROTEIN; MESSENGER RNA; MORPHOLINE DERIVATIVE; OLIGOMER; PEPTIDE; PHOSPHORODIAMIDATE MORPHOLINO OLIGOMER; POLYPEPTIDE; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL MEMBRANE PERMEABILITY; CELL NUCLEUS; COMPLEX FORMATION; CONJUGATION; CONTROLLED STUDY; CROSS LINKING; CYTOSOL; EMBRYO; GENE FUNCTION; HUMAN; HUMAN CELL; MOLECULAR SIZE; MOUSE; NONHUMAN; PROTEIN TARGETING; RNA SPLICING;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 1642321105     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc034221g     Document Type: Article

References (42)

1. Summerton, J., and Weller, D. (1997) Morpholino antisense oligomers: design, preparation, and properties. Antisense Nucleic Acid Drug Dev. 7, 187-195.
2. Summerton, J. (1999) Morpholino antisense oligomers: the case for an RNase H-independent structural type. Biochim. Biophys. Acta 1489, 141-158.
3. Taylor, M. F., Paulauskis, J. D., Weller, D. D., and Kobzik, L. (1996) In vitro efficacy of morpholino-modified antisense oligomers directed against tumor necrosis factor-alpha mRNA. J. Biol. Chem. 271, 17445-17452.
4. Taylor, M. F., Paulauskis, J. D., Weller, D. D., and Kobzik, L. (1997) Comparison of efficacy of antisense oligomers directed toward TNF-alpha in helper T and macrophage cell lines. Cytokine 9, 672-681.
5. Taylor, M. F., Weller, D. D., and Kobzik, L. (1998) Effect of TNF-alpha antisense oligomers on cytokine production by primary murine alveolar macrophages. Antisense Nucleic Acid Drug Dev. 8, 199-205.
6. Summerton, J., Stein, D., Huang, S. B., Matthews, P., Weller, D., and Partridge, M. (1997) Morpholino and phosphorothioate antisense oligomers compared in cell-free and in-cell systems. Antisense Nucleic Acid Drug Dev. 7, 63-70.
7. Hudziak, R. M., Summerton, J., Weller, D. D., and Iversen, P. L. (2000) Antiproliferative effects of steric blocking phosphorodiamidate morpholino antisense agents directed against c-myc. Antisense Nucleic Acid Drug Dev. 10, 163-176.
8. Stein, D. A., Skilling, D. E., Iversen, P. L., and Smith, A. W. (2001) Inhibition of Vesivirus infections in mammalian tissue culture with antisense morpholino oligomers. Antisense Nucleic Acid Drug Dev. 11, 317-325.
9. Nasevicius, A., Larson, J., and Ekker, S. C. (2000) Distinct requirements for zebrafish angiogenesis revealed by a VEGF-A morphant. Yeast 17, 294-301.
10. Heasman, J., Kofron, M., and Wylie, C. (2000) Beta-catenin signaling activity dissected in the early Xenopus embryo: a novel antisense approach. Dev. Biol. 222, 124-134.
11. Howard, E. W., Newman, L. A., Oleksyn, D. W., Angerer, R. C., and Angerer, L. M. (2001) SpKrl: a direct target of beta-catenin regulation required for endoderm differentiation in sea urchin embryos. Development 128, 365-375.
12. Kos, R., Reedy, M. V., Johnson, R. L., and Erickson, C. A. (2001) The winged-helix transcription factor FoxD3 is important for establishing the neural crest lineage and repressing melanogenesis in avian embryos. Development 128, 1467-1479.
13. Hudziak, R. M., Barofsky, E., Barofsky, D. F., Weller, D. L., Huang, S. B., and Weller, D. D. (1996) Resistance of morpholino phosphorodiamidate oligomers to enzymatic degradation. Antisense Nucleic Acid Drug Dev 6, 267-272.
14. Ghosh, C., and Iversen, P. L. (2000) Intracellular delivery strategies for antisense phosphorodiamidate morpholino oligomers. Antisense Nucleic Acid Drug Dev. 10, 263-274.
15. Morcos, P. A. (2001) Achieving efficient delivery of morpholino oligos in cultured cells. Genesis 30, 94-102.
16. Fawell, S., Seery, J., Daikh, Y., Moore, C., Chen, L. L., Pepinsky, B., and Barsoum, J. (1994) Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. U. S. A. 91, 664-668.
17. Derossi, D., Joliot, A. H., Chassaing, G., and Prochiantz, A. (1994) The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 269, 10444-10450.
18. Vives, E., Brodin, P., and Lebleu, B. (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272, 16010-16017.
19. Pooga, M., Soomets, U., Hallbrink, M., Valkna, A., Saar, K., Rezaei, K., Kahl, U., Hao, J. X., Xu, X. J., Wiesenfeld-Hallin, Z., Hokfelt, T., Bartfai, T., and Langel, U. (1998) Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat. Biotechnol. 16, 857-861.
20. Koppelhus, U., Awasthi, S. K., Zachar, V., Holst, H. U., Ebbesen, P., and Nielsen, P. E. (2002) Cell-dependent differential cellular uptake of PNA, peptides, and PNA-peptide conjugates. Antisense Nucleic Acid Drug Dev. 12, 51-63.
21. Richard, J. P., Melikov, K., Vives, E., Ramos, C., Verbeure, B., Gait, M. J., Chernomordik, L. V., and Lebleu, B. (2003) Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 278, 585-590.
22. Villa, R., Folini, M., Lualdi, S., Veronese, S., Daidone, M. G., and Zaffaroni, N. (2000) Inhibition of telomerase activity by a cell-penetrating peptide nucleic acid construct in human melanoma cells. FEBS Lett. 473, 241-248.
23. Ho, A., Schwarze, S. R., Mermelstein, S. J., Waksman, G., and Dowdy, S. F. (2001) Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo. Cancer Res. 61, 474-477.
24. Moulton, H. M., Hase, M. C., Smith, K. M., and Iversen, P. L. (2003) HIV Tat peptide enhances cellular delivery of antisense morpholino oligomers. Antisense Nucleic Acid Drug Dev. 13, 31-43.
25. Wender, P. A., Mitchell, D. J., Pattabiraman, K., Pelkey, E. T., Steinman, L., and Rothbard, J. B. (2000) The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Natl. Acad. Sci. U. S. A. 97, 13003-13008.
26. Futaki, S., Ohashi, W., Suzuki, T., Niwa, M., Tanaka, S., Ueda, K., Harashima, H., and Sugiura, Y. (2001) Stearylated arginine-rich peptides: a new class of transfection systems. Bioconjugate Chem. 12, 1005-1011.
27. Chen, L., Wright, L. R., Chen, C. H., Oliver, S. F., Wender, P. A., and Mochly-Rosen, D. (2001) Molecular transporters for peptides: delivery of a cardioprotective epsilonPKC agonist peptide into cells and intact ischemic heart using a transport system, R(7). Chem. Biol. 8, 1123-1129.
28. Kole, R. (1998) Modification of pre-mRNA splicing by antisense oligonucleotides. In Applied Antisense Oligonucleotides Technology (Stein, C. A. M., Ed.) pp 451-469, Wiley-Liss, Inc., New York.
29. Sierakowska, H., Sambade, M. J., Agrawal, S., and Kole, R. (1996) Repair of thalassemic human beta-globin mRNA in mammalian cells by antisense oligonucleotides. Proc. Natl. Acad. Sci. U. S. A. 93, 12840-12844.
30. Lacerra, G., Sierakowska, H., Carestia, C., Fucharoen, S., Summerton, J., Weller, D., and Kole, R. (2000) Restoration of hemoglobin A synthesis in erythroid cells from peripheral blood of thalassemic patients. Proc. Natl. Acad. Sci. U. S. A. 97, 9591-9596.
31. Sazani, P., Kang, S. H., Maier, M. A., Wei, C., Dillman, J., Summerton, J., Manoharan, M., and Kole, R. (2001) Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs. Nucleic Acids Res. 29, 3965-3974.
32. Kang, S. H., Cho, M. J., and Kole, R. (1998) Up-regulation of luciferase gene expression with antisense oligonucleotides: implications and applications in functional assay development. Biochemistry 37, 6235-6239.
33. Sazani, P., Gemignani, F., Kang, S. H., Maier, M. A., Manoharan, M., Persmark, M., Bortner, D., and Kole, R. (2002) Systemically delivered antisense oligomers upregulate gene expression in mouse tissues. Nat. Biotechnol. 20, 1228-1233.
34. Summerton, J., and Weller, D. (1991). Uncharged morpholino-based polymers having phosphorus containing chiral intersubunit linkages. US Patent 5185444.
35. Moulton, H. M., and Moulton, J. D. (2003) Peptide-assisted delivery of steric-blocking antisense oligomers. Curr. Opin. Mol. Ther. 5, 123-132.
36. Suzuki, T., Futaki, S., Niwa, M., Tanaka, S., Ueda, K., and Sugiura, Y. (2002) Possible existence of common internalization mechanisms among arginine-rich peptides. J. Biol. Chem. 277, 2437-2443.
37. Rothbard, J. B., Kreider, E., VanDeusen, C. L., Wright, L., Wylie, B. L., and Wender, P. A. (2002) Arginine-rich molecular transporters for drug delivery: role of backbone spacing in cellular uptake. J. Med. Chem. 45, 3612-3618.
38. Futaki, S., Nakase, I., Suzuki, T., Youjun, Z., and Sugiura, Y. (2002) Translocation of branched-chain arginine peptides through cell membranes: flexibility in the spatial disposition of positive charges in membrane-permeable peptides. Biochemistry 41, 7925-7930.
39. Feener, E. P., Shen, W. C., and Ryser, H. J. (1990) Cleavage of disulfide bonds in endocytosed macromolecules. A processing not associated with lysosomes or endosomes. J. Biol. Chem. 265, 18780-18785.
40. Mandel, R., Ryser, H. J., Niaki, B., Ghani, F., and Shen, W. C. (1991) Isolation of variants of Chinese hamster ovary cells with abnormally low levels of GSH: decreased ability to cleave endocytosed disulfide bonds. J. Cell Physiol. 149, 60-65.
41. Schwarze, S. R., Ho, A., Vocero-Akbani, A., and Dowdy, S. F. (1999) In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285, 1569-1572.
42. Lewin, M., Carlesso, N., Tung, C. H., Tang, X. W., Cory, D., Scadden, D. T., and Weissleder, R. (2000) Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. 18, 410-414.